Keywords: merck, co, otc, mevacor, go, before, fda

Merck & Co's OTC Mevacor to go before FDA in Dec

Article | 05 November 2007

Print This

US drug major Merck & Co has been advised that the New Drug Application for over-the-counter Mevacor (lovastatin) will be reviewed ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in